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Pherrylketonurta: implications of somc biochemical and clinical findings
Phenylketonuria (PK[I) is an inborn error of amino acid metabolism in which a
deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH) causes a
decreased hydroxylation of phenylalanine into tyrosine. Left untreated, PKU rezults
in serious mental retardation. However, PKU can be detect€d and treated in
neonates before damage to the central nervous system has occurred to a large
degree. The treatment is based on a diet restricted in natural protein and supplying
the patient with a tyrosine-enriched amino acid mixture devoid of phenylalanine
resulting in a more or less normal total protein intake. This treatrrent has
contributed considerably to the improvement of the intellectual outcome of these
patients, but even early treated PKU patients still encounter some abnormalities in
the intellectual, neurolopsychologic and psychosocial development. As the aim of
today should not only be to prevent mental retardation but also to enable patients
with PKU to develop as a normal and happy child into a normal adult with a normal
life, many questions need to be answered.
In this thesis, attention is paid to $owth which may be impaired due the severe
dietary Phe restriction; the possibility of distinction between patients with
differences in PAH enzyme activity by direct measuÍement of the in-vivo
phenylalanine hydroxylation; plasma Phe and Tyr concentrations in response to
different distributions of the daily intake of PKU patients; and some issues
concerning pregnancy and PKU.
In the introduction (chapter 1) some aspects of PKU are outlined which present
either some general background information or are very relevant to the issues
discussed in PKU today. Such iszues are the lack of clearness on the definition of
the term PKU, and the lack of consensus on the method used to differentiate
between patients with different levels of PAH deficiency. It is argued that dietary
restriction is the sole treaunent of choice with -on the one hand- large positive
effects, but -on the other hand, no complete norrral intellechral, neuropsychologic
and psychosocial development. Therefore, various iszues still need to be solved to
optimalize the treatment of PKU individuals from the unborn child to the adult and
the woman with PKU who carries a child herself.
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Summ.ary
In chapter 2, growth and the effect of different degrees of dietary restriction
were studied in Dutch patients with early and continuously treated PKU. In these
studies, it was found that growth retardation occurs during the first three years
of life, but that no relationship exists between different degrees of the strictness of
dietary treatment and the previously described growth retardation. The last finding is
important because the targetted phenylalanine concentrations have been decreased
during the recent years.
In chapter 3, the in-vivo hydroxylation of phenylalanine into tyrosine was
investigated using stable isotopically labelled phenylalanine and tyrosine. By this
method, theoretically, the hydroxylation rate of phenylalanine can be measured
without causing a substantial increase of the plasma phenylalanine concentration. In
this thesis it was shown that continuously treated PKU patients have decreased in-
vivo phenylalanine hydroxylation rates. This finding is in contrast with the results of
other studies. Further studies are needed to investigate the usefulness of this
technique in order to select between patients with differences in the degree of the
PAH deficiency at an early age.
In chapter 4 and 5, the daily fluctuations of both plasma phenylalanine and
tyrosine were studied in relation to different distributions of the daily -individually
tailored- dietary natural protein intake.
From the studies concerning the daily fluctuations of phenylalanine in plasma
(chapter 4) it was concluded that the nutritional condition (fasting/postprandial) and
the exact time of the day the blood sampling is performed are not important in the
evaluation of the phenylalanine intake, and that unequal distributions of the daily
phenylalanine allowance are justified in PKU patients on an occoasional base
provided that the patient is in good clinical condition, adjusted adequately to the
diet, and given that the daily allowance is not exceeded. Regarding these two
conclusions, it should be stressed that only patients older than 1 year of age were
studied and that further studies are necessary for patients younger than 1 year of
age.
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The studies of the daily fluctuations of tyrosine concentrations in plasma
(chapter 5) showed that these fluctuations can be large resulting in very
high tyrosine concenfations. These studies further showed tlnt even patients with
an even distribution of their protein intake may encounter both too low and too high
tyrosine concentrations at the same day. It could, therefore, be concluded that a
single blood sample either taken in the overnight fasting or postprandial condition
is insufficient to detect a possible tyrosine deficiency and that a combination of a
pre- and postprandial blood sample on the same day may be more effective. Second,
it could be concluded that strict control of plasma tyrosine is necessary when extra
tyrosine supplementation is considered in addition to the tyrosine-enriched amino
acid mixtures.
In chapter 6, different aspects concerning PKU and pregnancy were discussed,
including both the fetal condition of the PKU patient and that of the offspring of a
female patient with PKU (maternal PKI-D. It was shown that in PKU children the
risk of congenital heart disease and low birth weight may be increased. In this
chapter inforrration is also given on reference values of amino acid concentrations in
maternal blood which are necessary for the treafinent of maternal PKU.
In the general discussion (chapter 7) the results of chapter 2 to 6 are discussed.
Attention is focussed on the need of a method to distinguish between patients with
different PAH enzyme activity and the problems related to the method which is most
often used (phenylalanine tolerance at 5 years of age according to GËttler). Further,
difficulties in the treatment of maternal PKU are discussed. The chapter ends with a
short enumeration of aspects of treaÍnent which deserve special attention to
optimalize the intellectual and neuropsychologic outcome and to decrease the
psychosocial burdensome of the treatnent.
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